Richard Pazdur, MD, director of the FDA’s Oncology Center of Excellence, will present Expediting Oncology Drug Development in an Era of Breakthrough Therapies from 12-1P on March 31 in Fukushima Auditorium.

The Oncology Center of Excellence leverages the combined skills of the FDA’s regulatory scientists and reviewers with expertise in drugs, biologics and devices to expedite the development of novel cancer products as part of the Vice President’s National Cancer Moonshot Initiative. The special seminar is being presented by the WVU Cancer Institute.